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NS). However, patients developing AV sclerosis after inclusion had higher mean diastolic 
blood pressure after four years of treatment (83 vs. 80 mmHg, P<O.Ol). The incidence of 
AV stenosis was higher in patients with AV sclerosis compared to those with normal 
valves at baseline after one year (2.8% vs. 0.4%, PcO.001) and four years (6.9% vs. 
0.9%, P-=0.001) of treatment. Conclusion: The prevalence of AV sclerosis and mild AV 
stenosis increased quickly in an elderly high-risk hypertensive population and could not 
be prevented by treatment with losartan. Development of new AV sclerosis or stenosis 
was associated with suboptimal diastolic blood pressure control. Pabents with AV sclero- 
sis had significantly higher risk of progressing to mild AV stenosis, suggesting that AV 
stenosis often is preceded by sclerosis in hypertension. 
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1 IOSMP-167 Association of Cardiovascular Risk Factors to Aortic 
Valve Calcification as Quantified by Electron Beam 
Tomography 
Karsten Pohle, Merle Starke, Ralph MBffert, Dieter Ropers, Werner G. Daniel, Stephan 
Achenbach, University of Erlangen, Erlangen, Germany 
Electron beam tomography (EBT) allows the detection and exact quantification of calcifi- 
cations in coronary vessels (CC) and in the aortic valve (AVC). The aim of this study was 
to analyze the association of cardiovascular dsk factors, CC and AVC. 
Methods: We analyzed cardiac EBT data sets of 1000 consecutive patients (57.1+/-10 
years, 69% men) without an established diagnosis of coronary artery disease, which had 
been obtained for the detection of CC on an outpatient basis. In all patients, atheroscle- 
rotic risk factors (hyperlipidaemia [HL], hypertension [HTN], diabetes [DM], smoking) 
were documented. In all EBT studies, the amount of CC (“Agatston Score”) and of AVC 
(volumetric score) was measured. 
Results: In 17.7% of patients, AVC were found (volume score 41.6+/-219 mma). In 
82.9%, CC were present (Agatston Score 270.3+/s615). The amount of AVC and CC 
showed a weak but statistically significant correlation (wO.21, p<O.OOl). AVC were more 
frequently found in patients with CC as compared to patients without CC (20.5% vs. 
3.8%. pcO.OOl), in patients with HL [19.5% vs. 6.5%. p<O.OOl], HTN [21.7% vs. 13.9%, 
p=O.Ol] and DM [30.7% vs. 16.6%, p=O.O02]. No statistically significant correlation was 
observed for smoking [19.4% vs. 15.6%, p=O.ll]. AVC were found in 2.4% of patients 
without atherosclerotic risk factors, but in 33.3% of patients presenting all 4 nsk factors 
(pcO.001). The mean volume of AVC was significantly increased in patients with HL 
(48.0+/-237mm3 vs. 5.7 33mti, p<O.OOl) and DM (93.9+/-379mm9 vs. 37.5+/-201mm3, 
p=O.O3), while no such relationship was observed for smoking (46.0+/-222mm3 YS. 36.3+/ 
-216mm3, p=O.2) and HTN (52.1+/-259mm3 vs. 32.5+/-176mm3, p=O.l). 
Conclusion: In this study, a significant association was found between atherosclerotic 
risk factors, coronary calcifications and the presence and amount of calcifications of the 
aortic valve. 
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1109MP-168 Risk Stratification in Mild and Moderate Aortic Stenosis 
by Assessment of Aortic Valve Calcification 
Raphael Rosenhek Ursula Klaar, Christine Scholten, Maria Heger, Harald Gabriel, 
Thomas Binder, Gerald Maurer, Helmut Baumganner, University of Vienna, Vienna, 
Austria 
Background: The degree of aortic valve calcification (AV-Calc) has been shown to be a 
significant predictor of outcome in severe aortic stenosis (AS). In addition, aortic sclero- 
sis has recently been reported to be associated with increased mortality. However, it 
remains unknown whether the,degree of AV-Cald is of prognostic value in mild and mod- 
erate AS. 
Methods: 176 consecutive pts. (73 F, age 58+/-19 yrs) with mild to moderate AS (peak 
aortic jet velocity (AV-Vel) between 2.5 and 4.0 m/s) were followed for 5lil8 mths. The 
degree of AV-Calc and other risk factors were assessed. The rate of hemodynamic pro- 
gression was determined and the clinical outcome analyzed. 
Results: During follow-up, 15 cardiac and 19 non-cardiac deaths occurred. Mortality was 
1.8 times higher than that of an age and gender _ matched control population (p<.OO5). 
Kaplan-Meier event-free survival for the entire pt. group, with endpoints defined as death 
(n=34) or aortic valve surgery (n=33) was 95+/-2 % at 1 yr, 75+/-3 % at 3 yrs. and 60+/-5 
% at 5 yrs. By multivariate analysis, moderate or severe AV-Calc, coronary artery dis- 
ease (CAD) and AV-Vel at entry were significant independent predictors of outcome 
(p<.OoOl, p<.OOl and pc.01, respectively). Event-free survival for patients with moderate 
or severe AV-Calc was 92+/-4% at 1 yr, 61+/-7% at 3 and 42+/-7% at 5 yrs versus 1 OO%, 
90+/-4% and 82+/-5% for patients with no or mild AV-Cak. Diabetes, hypercholesteremia 
and hypertension did not predict outcome. The rate of hemodynamic progression was 
significantly faster for pts. with event (0.43+/-0.04 m/s/yr) than for those without (0.14+/- 
0.02 m/s/yr, pc.0001). Of 129 pts. with a follow-up echocardiographic exam, 59 (46%) 
developed severe AS during follow-up. 
Conclusion: Rapid progression to severe AS and an increased mortality have to be con- 
sidered in mild and moderate AS. Particularly pts. with significant AV-Calc but also those 
with CAD and pts. with a rapid progression of the AV-Vel have a poor outcome. Serial 
Doppler studies and the assessment of AV-Cak are important for the management of 
these pts. as they identify high-risk pts. who require closer follow-up than currently rec- 
ommended. 
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Relation of Mitral Annular Calcification to 
Cardiovascular Risk Factors and Cardiovascular 
Mortality in Adults With Type 2 Diabetes: The Strong 
Heart Study 
Jennrfer E. Liu New York Hospital Weill Cornell Medical Center, New York, NY 
Background: Mitral annular calcificatron (MAC) is frequently seen on routine echocardio- 
gram in adults with type II diabetes (DM). However, whether MAC is associated with car- 
diovascular (CV) risk factors and subsequent CV events is not well defined. Methods: We 
compared two groups of DM American Indians based on the presence (n= 182) or 
absence (n= 1278) of MAC on echocardiogram. Results: DM with MAC were older (63 
vs. 60 years) with higher systolic blood pressure(l36 vs 133 mm Hg), higher total choles- 
terol (193 vs. 188 mg/dl) and higher urinary creatinine/albumin ratio (uacr) (1093 vs. 698, 
all p<O.OOl) as compared to DM without MAC. There was no difference in gender, body 
mass index or prevalence of smoking. DM with MAC had higher left ventricular (LV) 
mass (176 vs. 181 gm), higher prevalence of LV hypertrophy (18 vs. 10%) lower stress- 
corrected midwall shortening (98 vs. 103%) and lower mitral E/A ratio (0.75 vs. 0.81, all 
p<O.O05) as compared to DM without MAC. The prevalence of coronary heart disease 
and CV mortality and total mortality are as shown. 
On multivariate analysis adjustrng for age, systolic blood pressure, cholesterol and uacr, 
MAC was not found to be independently associated with prevalence of coronary heart 
disease, CV and total deaths. CONCLUSION: MAC is associated with abnormal LV 
structure and function in the DM population. The higher prevalence of coronary heart dis- 
ease and a higher total mortality in DM with MAC IS likely mediated by a larger burden of 
CV risk factors 
Prevalence of coronary heart disease 
No MAC 
7.2% 
MAC P value 
11.7% 0.03 
CV Death 3.9% 
All Death 8.3% 
1109MP-170 Impact of Systolic Hypertension and Impedance 
Lowering Drugs on Clinical Outcomes in Chronic 
Severe Aortic Regurgitation 
2.4% NS 
13.1% 0.05 
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Phyllis G. Supine, Jeffrey S. Borer, Glare A. Hochreiter, Edmund M. Herrold, Richard B. 
Devereux, Mary J. Roman, Paul D. Kligfield, Elaine Dillingham, Weill Medical College of 
Cornell University, New York, NY 
Background: The prevalence of systolic hypertension (HTN) coexisting with aortrc regur- 
gitation (AR) and the impact of HTN on AR natural history are poorly defined. Such data 
are important: previous trials of impedance lowering drugs (ILRx) for AR were done 
largely in pts with HTN and suggest improvement in LV size and function. However, few 
data have elucidated ILRx effect on clinical outcome and ILRx effect in AR without HTN 
is unknown. To explore these issues, we retrospectively reviewed our ongoing prospec- 
tive study of AR natural history and outcome predictors. 
Methods: Among 73 unoperated pts with chronic severe AR (83% male, 44*15 yrs old at 
entry) who entered the study asymptomatic with normal LV ejection fraction (EF) at 
rest(r), we related HTN (history and/or study entry systolic blood pressure>l40) to subse- 
quent cardiac events (CE) during 7+4 event-free yrs. We also evaluated ILRx effect in pts 
with and without HTN. 
Results: At study entry, 29/73(40%) pts had HTN; 17/29(59%) pts with HTN and 3/ 
44(7%) without HTN were taking ILRx chronically (not protocol-mandated): diuretics(8 
pts), ACE inhibitors(5 pts), direct vasodilators(4 pts), combination ILRx(3 pts). During fol- 
lowup, 2 pts died suddenly, 17 pts developed CHF f subnl LVEFr and 5 developed subnl 
LVEFr alone. HTN predicted increased risk of CE (9.2%/yr vs 3.2%&r without HTN, 
p=.OO2) and remained predictive after adjustment for age and gender (p.z.02). Among pts 
with HTN. risk for CE was 4-fold greater in pts taking ILRx chronically(l5.5%/yr) vs those 
without chronic ILRx use(3.7%/yr, pc.02); among pts without HTN, risk was 0% with ILRx 
vs.3%/yr without (NS) but small subgroup size limits inferences in these pts. 
Conclusions: Systolic HTN occurs frequently in asymptomatic pts with chronic severe AR 
and portends a poor clinical outcome. Data were insufficient to evaluate individual drug 
classes but ILRx as a group do not mitigate the impact of HTN; at least some of these 
drugs may be deleterious. ILRx effect in pts without HTN remains unclear. Future 
research must determine why theoretically beneficial ILRx was ineffective for clinical out- 
come and, specifically, whether drug class, dose, etc., interact with clinical effect. 
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1109MP-171 Early Predictors of Mortality in Patients With 
Endocarditis 
Vivian Chu Christopher Cabell, Erin Kuniholm, Danny Benjamrn, John Engemann, Laura -1 
Meyer, Vance Fowler, Andrew Wang, Duke University Medical Center, Durham, NC 
Background: Infective endocarditis (IE) is associated with significant mortality, but prog- 
nostic factors remain poorly defined. We evaluated early prognostic factors in patients 
with IE, including severity of illness, to determine those independently associated with 
death. 
Methods: Clinical, microbrologic and echo data of patients with definite or possible IE by 
Duke criteria from 1996.2001 (n=351) were collected prospectively in the Duke IE data- 
